eGenesis (@egenesisbio) 's Twitter Profile
eGenesis

@egenesisbio

eGenesis is developing genetically-engineered human-compatible organs for #transplantation 🧬🧬

ID: 2474718272

linkhttp://www.egenesisbio.com calendar_today03-05-2014 00:35:02

315 Tweet

1,1K Takipçi

288 Takip Edilen

MassGeneral News (@massgeneralnews) 's Twitter Profile Photo

Mass General set another milestone. Jan 25th marked our 2nd successful xenotransplant of a genetically-edited pig kidney into a living recipient. Tim Andrews is now the 4th person in the world to receive a genetically-edited pig kidney. spklr.io/6016F2g0

Mass General set another milestone. Jan 25th marked our 2nd successful xenotransplant of a genetically-edited pig kidney into a living recipient. Tim Andrews is now the 4th person in the world to receive a genetically-edited pig kidney. spklr.io/6016F2g0
Peter Hebert (@peterjhebert) 's Twitter Profile Photo

Filled with pride on behalf of eGenesis scientists and researchers, who along with their partners at MassGeneral Medicine, are saving lives and propelling humanity forward

Josh Wolfe (@wolfejosh) 's Twitter Profile Photo

1/ We had to keep this news secret until today. (I like to quote Nobel Prize winner Linus Pauling on the endlessly addictive pursuit of secrets in science tech or VC: I know something the world doesn't know and they won't know til I tell em) To put this news in perspective...

1/ We had to keep this news secret until today. 

(I like to quote Nobel Prize winner Linus Pauling on the endlessly addictive pursuit of secrets in science tech or VC: I know something the world doesn't know and they won't know til I tell em)

To put this news in perspective...
Lux Capital (@lux_capital) 's Twitter Profile Photo

Proud investors! Congratulations to @egenesisbio on their 2nd successful xenotransplantation! A major milestone in addressing the global organ shortage crisis 🚀🧪✨

eGenesis (@egenesisbio) 's Twitter Profile Photo

.CNN spoke with our CEO Mike Curtis about the amazing work being done at Mass General Transplant and our second successful porcine kidney transplant into a living human recipient. Read the article: lnkd.in/ewhTEA2X

.<a href="/CNN/">CNN</a> spoke with our CEO Mike Curtis about the amazing work being done at <a href="/mgh_transplant/">Mass General Transplant</a> and our second successful porcine kidney transplant into a living human recipient. 

Read the article: 
lnkd.in/ewhTEA2X
Lux Capital (@lux_capital) 's Twitter Profile Photo

Lux fam co eGenesis is at the forefront of a groundbreaking solution to the critical organ shortage crisis. Through xenotransplantation, they're truly turning sci-fi into sci-fact 🚀🧬 We’re proud to be part of this transformative journey in medical science. More from

eGenesis (@egenesisbio) 's Twitter Profile Photo

Excited to share our story with The New York Times Roni Rabin. Thanks for speaking with our team about our work in #organ #transplantation. 🧬🧬 Sharing the article: shorturl.at/33BSM

Excited to share our story with <a href="/nytimes/">The New York Times</a> <a href="/RoniNYTimes/">Roni Rabin</a>. Thanks for speaking with our team about our work in #organ #transplantation. 🧬🧬

Sharing the article:

shorturl.at/33BSM
Abu Dhabi Global Health Week (@adghwtweets) 's Twitter Profile Photo

The future of healthcare starts at the Forum @ ADGHW, taking place from 15–17 April 2025 at ADNEC Centre Abu Dhabi, and bringing together the world’s foremost health leaders, innovators, and policymakers for a transformative three-day conference. Get ready to hear from renowned

Abu Dhabi Global Health Week (@adghwtweets) 's Twitter Profile Photo

Speaking on the advancement of genetic medicines, one of the main challenges in the field is scaling safely, Dr. Mike Curtis, President and CEO eGenesis, tells #ADGHW #TowardsLongevityRedefiningHealthAndWellBeing

eGenesis (@egenesisbio) 's Twitter Profile Photo

We’re excited to announce the FDA has cleared our IND application for the treatment of patients with acute on chronic liver failure with the OrganOx ELC system. Read the release: businesswire.com/news/home/2025…

We’re excited to announce the FDA has cleared our IND application for the treatment of patients with acute on chronic liver failure with the <a href="/organ_ox/">OrganOx</a> ELC system. 

Read the release:

businesswire.com/news/home/2025…
Abu Dhabi Global Health Week (@adghwtweets) 's Twitter Profile Photo

The Forum @ ADGHW hosted 'Scaling Precision Medicine in Longevity', a session that examined how tailored therapies and data-driven insights are unlocking new frontiers in healthy ageing. It marked a pivotal step in shaping how longevity is personalised and scaled globally. We

The Forum @ ADGHW hosted 'Scaling Precision Medicine in Longevity', a session that examined how tailored therapies and data-driven insights are unlocking new frontiers in healthy ageing. It marked a pivotal step in shaping how longevity is personalised and scaled globally.

We
Boston Business Journal (@bosbizjournal) 's Twitter Profile Photo

Cambridge-based eGenesis now has FDA permission to test its human-compatible, genetically engineered pig liver in clinical trials for the first time. bizjournals.com/boston/news/20…

National Geographic (@natgeo) 's Twitter Profile Photo

The answer to the organ donor crisis could be rolling in the mud: pigs. Biotech firm eGenesis is designing, cloning, and raising pigs whose kidneys can be used in human transplant patients without the risk of acute and immediate rejection. on.natgeo.com/3GA2seI

The answer to the organ donor crisis could be rolling in the mud: pigs. Biotech firm eGenesis is designing, cloning, and raising pigs whose kidneys can be used in human transplant patients without the risk of acute and immediate rejection. on.natgeo.com/3GA2seI
SynBioBeta (@synbiobeta) 's Twitter Profile Photo

Excited to have Dr. Wenning Qin, CEO of eGenesis, speaking at #SynBioBeta 2025! Discover how synthetic biology and genome engineering are solving the organ shortage crisis. Join us and see the future unfold! #SynBio #Biotech #Xenotransplantation

Excited to have Dr. Wenning Qin, CEO of <a href="/eGenesisBio/">eGenesis</a>, speaking at #SynBioBeta 2025! Discover how synthetic biology and genome engineering are solving the organ shortage crisis. Join us and see the future unfold! 

#SynBio #Biotech #Xenotransplantation
Josh Wolfe (@wolfejosh) 's Twitter Profile Photo

1/ Three big Lux things tonight -Anduril Industries founder Palmer Luckey on 60 Minutes “The Future of Warfare” -eGenesis on CNN with Sanjay Gupta “Animal Pharm” -new Lux Q1 2025 Quarterly Letter

1/ Three big Lux things tonight

-<a href="/anduriltech/">Anduril Industries</a> founder Palmer Luckey on <a href="/60Minutes/">60 Minutes</a> 
“The Future of Warfare”

-<a href="/eGenesisBio/">eGenesis</a> on <a href="/CNN/">CNN</a> with Sanjay Gupta 
“Animal Pharm”

-new Lux Q1 2025 Quarterly Letter
Peter Hebert (@peterjhebert) 's Twitter Profile Photo

The magic of eGenesis: turning science fiction (employing gene editing + genome engineering to transplant pig kidneys into human beings) into everyday "life" boston25news.com/news/local/nh-…

eGenesis (@egenesisbio) 's Twitter Profile Photo

Yesterday was one of those unforgettable moments. Watching Tim Andrews throw out the first pitch at Fenway Park was pretty incredible and a powerful reminder of why we do this work. ⚾ Thank you to our partners at MGH. #Transplantation #Fenway #MGH wcvb.com/article/man-wh…

Yesterday was one of those unforgettable moments.

Watching Tim Andrews throw out the first pitch at Fenway Park was pretty incredible and a powerful reminder of why we do this work. ⚾

Thank you to our partners at MGH. 

#Transplantation #Fenway #MGH 

wcvb.com/article/man-wh…